Cargando…
DDX3 enhances oncogenic KRAS-induced tumor invasion in colorectal cancer via the β-catenin/ZEB1 axis
DDX3 plays a dual role in colorectal cancer; however, the role and underlying mechanism of DDX3 in colorectal tumorigenesis remains unclear. Here, we provide evidence that DDX3 enhances oncogenic KRAS transcription via an increase in SP1 binding to its promoter. Accelerating oncogenic KRAS expressio...
Autores principales: | Wu, De-Wei, Lin, Po-Lin, Cheng, Ya-Wen, Huang, Chi-Chou, Wang, Lee, Lee, Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008392/ https://www.ncbi.nlm.nih.gov/pubmed/27007150 http://dx.doi.org/10.18632/oncotarget.8143 |
Ejemplares similares
-
The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer
por: Wu, De-Wei, et al.
Publicado: (2017) -
DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis
por: He, Tsung-Ying, et al.
Publicado: (2016) -
Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β‐catenin/ZEB1 axis
por: Lee, Hyunjung, et al.
Publicado: (2021) -
Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer
por: Lemieux, E, et al.
Publicado: (2015) -
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)